Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Lyxor launches UCITS fund that replicates Winton Capital’s Diversified Program

Monday, March 18, 2013
Opalesque Industry Update - Lyxor Asset Management announces the launch of a new UCITS-compliant fund which aims to replicate Winton Capital Management Ltd.’s Diversified Program. This bespoke UCITS compliant strategy is designed to: give access to a direct and genuine exposure to Winton’s management expertise through direct investments in UCITS eligible assets

Winton is a global investment manager with approximately $26bn in AuM and employs over 275 staff, close to half of whom are directly involved in research. The Winton trading strategy is focused on scientific research into financial markets which is led by its founder, David Harding, one of the pioneers of systematic trading in Europe. David Harding, founder and president of Winton, commented: “We are very pleased to work with Lyxor to provide their UCITS investors with our trading strategy. We’ve been working with Lyxor for more than 10 years and its long and solid experience offers investors a secure, controlled, framework available through its platform”.

The fund will be available on Lyxor’s alternative UCITS Platform. The strategy is based on the assumption that in the long term, profit can be derived from the futures markets by using statistical research into market activity and as a result, research constitutes the largest area of investment in the company.

The Fund's investment philosophy is that specific market behavior and trends can be identified and profitably exploited. In particular, the Fund will focus on the analysis of market prices and volumes in order to capture trends through liquid financial instruments including futures and forward currency contracts.

The Fund will be available in EUR, USD, GBP as well as other currencies upon investor’s requests.

Investors in the Fund will also benefit from the weekly liquidity and independent risk management provided by Lyxor.

With $11bn assets under management, Lyxor’s Managed Account Platform gives access to over 100 managers, selected among the best in the industry. With the addition of weekly liquidity, unrivalled transparency and sophisticated monitoring features, Lyxor MAP addresses what Lyxor believes to be investor’s current key decision criteria.

press release

www.lyxor.com

www.wintoncapital.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und